SCHEMBL17489713

SCHEMBL17489713

c1cncc(-c2ncnc3[nH]cnc23)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK5 Q00535 1/20 0.47
▸ CDK5R1 Q15078 1/20 0.47
▸ MAPK1 P28482 3/20 0.44
▸ CYP2A6 P11509 6/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ CYP2E1 P05181 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2B6 P20813 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ QPCT Q16769 1/20 0.43
▸ QPCTL Q9NXS2 1/20 0.43
▸ FFAR2 O15552 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ NUDT1 P36639 1/20 0.41
▸ LRRK2 Q5S007 2/20 0.40
▸ IDO1 P14902 1/20 0.40
▸ PIM1 P11309 1/20 0.39
▸ PIK3CD O00329 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2938674 0.82 JAK2 (0.54) CDK5CDK5R1CYP3A4FFAR2ALDH1A1
SCHEMBL4008997 0.75 JAK2 (0.69) CDK5MAPK1NUDT1LRRK2PIM1
Adenine SCHEMBL1134804 0.74 PI4KB (0.43) MAPK1CYP3A4QPCTQPCTLCYP1A2
SCHEMBL28780888 0.74 JAK2 (0.36) CYP3A4KDM4EMAPT
SCHEMBL30850661 0.73 KDM4C (0.59) MAPK1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL17017484 0.73 KDM4C (0.59) MAPK1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL28668955 0.72 MTOR (0.43) CDK5LRRK2PIM1PIK3CDABL1
SCHEMBL11004734 0.72 LMNA (0.46) CDK5CDK5R1MAPK1CYP2A6CYP3A4
SCHEMBL30527139 0.72 KDM4A (0.55) CDK5CDK5R1CYP2A6LRRK2PIM1
SCHEMBL17364297 0.71 ULK1 (0.44) CDK5CDK5R1MAPK1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2647637-B1 PURINYLPYRIDINYLAMINO-2,4-DIFLUOROPHENYL SULFONAMIDE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION WITH INHIBITORY ACTIVITY AGAINST RAF KINASE, CONTAINING SAME AS ACTIVE INGREDIENT MEDPACTO INC (KR) 2016-02-03 — — EP disclosed
Send feedback